Your browser doesn't support javascript.
loading
Alpha 2 agonists for sedation to produce better outcomes from critical illness (A2B Trial): protocol for a multicentre phase 3 pragmatic clinical and cost-effectiveness randomised trial in the UK.
Walsh, Timothy Simon; Aitken, Leanne M; McKenzie, Cathrine A; Boyd, Julia; Macdonald, Alix; Giddings, Annabel; Hope, David; Norrie, John; Weir, Christopher; Parker, Richard Anthony; Lone, Nazir I; Emerson, Lydia; Kydonaki, Kalliopi; Creagh-Brown, Benedict; Morris, Stephen; McAuley, Daniel Francis; Dark, Paul; Wise, Matt P; Gordon, Anthony C; Perkins, Gavin; Reade, Michael; Blackwood, Bronagh; MacLullich, Alasdair; Glen, Robert; Page, Valerie J.
Afiliação
  • Walsh TS; The University of Edinburgh Usher Institute of Population Health Sciences and Informatics, Edinburgh, UK twalsh@staffmail.ed.ac.uk.
  • Aitken LM; City University of London, London, UK.
  • McKenzie CA; University of Southampton, Southampton, UK.
  • Boyd J; Edinburgh Clinical Trials Unit, The University of Edinburgh Usher Institute of Population Health Sciences and Informatics, Edinburgh, UK.
  • Macdonald A; The University of Edinburgh Usher Institute of Population Health Sciences and Informatics, Edinburgh, UK.
  • Giddings A; The University of Edinburgh Usher Institute of Population Health Sciences and Informatics, Edinburgh, UK.
  • Hope D; NHS Lothian, Edinburgh, UK.
  • Norrie J; Usher Institute, Edinburgh Clinical Trials Unit, University of Edinburgh No. 9, Bioquarter, Edinburgh, UK.
  • Weir C; Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, Edinburgh, UK.
  • Parker RA; Edinburgh Clinical Trials Unit, University of Edinburgh, Edinburgh, UK.
  • Lone NI; The University of Edinburgh Usher Institute of Population Health Sciences and Informatics, Edinburgh, UK.
  • Emerson L; City University of London, London, UK.
  • Kydonaki K; Edinburgh Napier University, Edinburgh, UK.
  • Creagh-Brown B; Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK.
  • Morris S; Intensive Care Unit, Royal Surrey County Hospital, Guildford, UK.
  • McAuley DF; Primary Care Unit, University of Cambridge, Cambridge, UK.
  • Dark P; Centre for Experimental Medicine, Queen's University Belfast, Belfast, UK.
  • Wise MP; Intensive Care Unit, University of Manchester, Greater Manchester, UK.
  • Gordon AC; Department of Adult Critical Care, University Hospital of Wales, Cardiff, UK.
  • Perkins G; Section of Anaesthetics, Pain Medicine and Intensive Care, Imperial College London, London, UK.
  • Reade M; Clinical Trials Unit, University of Warwick, Birmingham, UK.
  • Blackwood B; University of Queensland, Brisbane, Queensland, Australia.
  • MacLullich A; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK.
  • Glen R; Geriatric Medicine Unit, University of Edinburgh, Edinburgh, UK.
  • Page VJ; NHS Lothian, Edinburgh, UK.
BMJ Open ; 13(12): e078645, 2023 12 10.
Article em En | MEDLINE | ID: mdl-38072483
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 Problema de saúde: 1_financiamento_saude Assunto principal: Propofol / Dexmedetomidina Limite: Adult / Humans País/Região como assunto: Europa Idioma: En Revista: BMJ Open Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 Problema de saúde: 1_financiamento_saude Assunto principal: Propofol / Dexmedetomidina Limite: Adult / Humans País/Região como assunto: Europa Idioma: En Revista: BMJ Open Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido